A drug costs $272,000 a year. Not so fast, says New York State.

New York Times

24 June 2018 - New York’s Medicaid program says Orkambi, a new drug to treat cystic fibrosis, is not worth the price. The case is being closely watched around the country.

A wave of breakthrough drugs is transforming the medical world, offering hope for people with deadly diseases despite their dizzying price tags.

But what if it turns out that some of these expensive new drugs don’t work that well?

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder